NHC CEO Marc Boutin, in an interview with Patient Focused Medicines Development, states, "We need treatments that reflect values that are important to patients."
NHC Assistant Vice President of Government Affairs, Eric Gascho, participated in a webinar on how to getmental health and substance use insurance coverage in the health insurance exchanges. A recording of the webinar is available online.
NHC CEO Marc Boutin participated in a panel on the value of PCOR in the real world during the 2015 PCORI Annual Meeting. A recording of the panel discussion is available online.
NHC CEO Marc Boutin participated on a panel discussing the challenges and opportunities in turning new evidence into clinical practice during the 2015 PCORI Annual Meeting. A recording of the panel discussion is available online.
NHC CEO Marc Boutin discusses how asking patients about what is going on in their lives could inform treatment, and how the current health care system in the United States makes this type of patient-physician relationship difficult.
NHC CEO Marc Boutin participated on a panel during Research!America's 2015 National Health Research Forum. The panel focused on the challenge and promise of regulatory science.
National Health Council CEO Marc Boutin participated on a panel discussing the Bipartisan Policy Council's report on Advancing Medical Innovation for a Healthier America and the need to incorporate the patient voice into every stage of the continuum to create new and better treatments for people with chronic conditions.
NHC CEO Marc Boutin is interviewed by Pure Communications Chief Communications Specialist Mike Huckman.
NHC CEO Marc Boutin talks to AJMCtv about how the health care industry can balance the growing pressures of improving quality and reducing costs while remaining patient-focused.
National Health Council CEO Marc Boutin participated on a panel about patient engagement in the drug development process during an even hosted by The Hill. The event focused on ways to accelerate the drug development process and initiatives that could help spur the growth of potential cures and new medicines.
While federal rules set minimum requirements for consumer protections, some states have acted to make their markets more patient-focused. To understand how states are addressing the needs and concerns of people with chronic conditions, the National Health Council worked together with Avalere Health to develop state-by-state performance reports based on the NHC’s five principles for enhancing the exchanges.
With the help of Lake Research Partners, the National Health Council undertook a first-of-its-kind study focusing solely on people living with chronic diseases and their family caregivers, with a goal of understanding patient needs when utilizing the insurance exchanges to purchase health plans. The results of the study were presented at a briefing for patient organizations on March 20, 2015.
Patients are thankful for the benefits created by the Affordable Care Act, but that they are hungry for more information to help them find the right plan that meets their health and budget needs. To review the latest patient protections and transparency requirements included as part of the 2016 Notice of Benefit and Payment Parameters and Letter to Issuers, three representatives from the Center for Consumer Information and Insurance Oversight (CCIIO), which is part of the Centers for Medicare and Medicaid Services (CMS), presented at a March 20, 2015, briefing hosted by the NHC.
Speaking at the NHC's 2015 Voluntary Health Leadership Conference, Debbie King, Chief Executive Officer of DSK Solutions, discussed how patient advocacy organizations can use "big data" to advance their mission-driven initiatives.
Speaking at the NHC's 2015 Voluntary Health Leadership Conference, Anton Hoos, MD, Head of Medical R&D Europe at Amgen, describes his company's vision of successful patient engagement in the development of new treatments and cures.
Speaking at the NHC's 2015 Voluntary Health Leadership Conference, Barbara Newhouse, President and CEO of The ALS Association, shared her thoughts about the Ice Bucket Challenge, which raised millions of dollars for her patient advocacy organization.
Speaking at the NHC's 2015 Voluntary Health Leadership Conference, Steve Ubl, President and CEO of AdvaMed, discussed the critical importance of patient involvement in the development of new treatments.
Speaking at the NHC's 2015 Voluntary Health Leadership Conference, Jim Greenwood, President and CEO of BIO, discussed how the patient community and industry can work together to advance the discovery of new treatments and cures.
Speaking at the NHC's 2015 Voluntary Health Leadership Conference, John Castellani, President and CEO, PhRMA, discussed the critical importance of patient involvement in the drug discovery process.
Speaking at the NHC's 2015 Voluntary Health Leadership Conference, Michael Rosenblatt, MD, Executive Vice President and Chief Medical Officer at Merck, discussed his company's vision for engaging patients in drug research.